tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Algorae Pharmaceuticals Releases 2025 Corporate Governance Statement

Story Highlights
  • Algorae Pharmaceuticals has released its corporate governance statement for 2025.
  • The statement confirms compliance with ASX governance recommendations, enhancing transparency.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Algorae Pharmaceuticals Releases 2025 Corporate Governance Statement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Living Cell Technologies ( (AU:1AI) ) has provided an update.

Algorae Pharmaceuticals Ltd has released its corporate governance statement for the financial year ending 30 June 2025, which is available on their website. The statement confirms compliance with ASX Corporate Governance Council’s recommendations, detailing the roles and responsibilities of the board and management, and the accountability of the company secretary to the board. This announcement underscores Algorae Pharmaceuticals’ commitment to transparency and adherence to governance standards, potentially strengthening stakeholder confidence.

More about Living Cell Technologies

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$13.5M

Learn more about 1AI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1